DIFLUCAN 10 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

diflucan 10 mg/ml

fareva amboise - franta - fluconazolum - pulb. pt. susp. orala - 10mg/ml - antimicotice de uz sistemic derivati de triazol

DIFLUCAN 150 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

diflucan 150 mg

fareva amboise - franta - fluconazolum - caps. - 150mg - antimicotice de uz sistemic derivati de triazol

DIFLUCAN 2mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

diflucan 2mg/ml

fareva amboise - franta - fluconazolum - sol. perf. - 2mg/ml - antimicotice de uz sistemic derivati de triazol

DIFLUCAN 50 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

diflucan 50 mg

fareva amboise - franta - fluconazolum - caps. - 50mg - antimicotice de uz sistemic derivati de triazol

Hepcludex Uniunea Europeană - română - EMA (European Medicines Agency)

hepcludex

gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - antivirale pentru uz sistemic - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.

Copiktra Uniunea Europeană - română - EMA (European Medicines Agency)

copiktra

secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - agenți antineoplazici - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies.  follicular lymphoma (fl) that is refractory to at least two prior  systemic therapies.